BioXcel Therapeutics, Inc.
The U.S. Bankruptcy Court for the District of Delaware docketed a voluntary Chapter 11 petition by BioXcel Therapeutics, Inc. on Aug 27, 2026 (case no. 26-11360).
BioXcel Therapeutics, Inc. — Chapter 11 reorganization petition filed Aug 27, 2026.
Background on Chapter 11: A Chapter 11 filing puts the automatic stay in place and starts the plan process. Unsecured creditors may see an official committee formed by the U.S. Trustee; claims are usually managed by a court-approved claims agent in larger cases.
This page reflects the petition filed on Aug 27, 2026. Later docket events (dismissal, conversion, plan confirmation, final decree, closing) are added when they appear in the court's public RSS feed, which not every court publishes in full, so the absence of such an event here does not mean the case is still open. Check the official record: court docket (PACER) and CourtListener.
Affiliated debtors (2)
Related entities that filed in the same court on the same day under consecutive case numbers. Courts normally administer such cases jointly under the lead case.
- OnkosXcel Employee Holdings, LLC26-11361
- OnkosXcel Therapeutics, LLC26-11362
What usually happens next
The filing date is from the docket; later milestones are the typical sequence for this chapter, not tracked events.
Where the case was filed
Court location (state level)
Pin placed at the state level (Delaware), not at the debtor's address. Map © OpenStreetMap.
About this filing
Summary of a public court record, provided as is. Not legal advice and not an official court document.